2252.HK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:30):

Shanghai Microport Medbot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China and Europe...

Stats
Dzisiejszy wolumen	520 500
Średni wolumen	1.14M
Kapitalizacja rynkowa	14.09B
EPS	HKD0 ( 2024-03-29 )
Następna data zysków	( HKD0 ) 2024-06-20
Last Dividend	HKD0 ( N/A )
Next Dividend	HKD0 ( N/A )
P/E	-12.87
ATR14	HKD0.0280 (0.19%)

Wolumen Korelacja

Długi: -0.05 (neutral)

Krótki: 0.19 (neutral)

Signal:(51.887) Neutral

Shanghai MicroPort MedBot Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Shanghai MicroPort MedBot Korelacja - Waluta/Towar

0.25
( neutral )

-0.03
( neutral )

0.00
( neutral )

-0.19
( neutral )

-0.42
( neutral )

-0.11
( neutral )

Shanghai MicroPort MedBot Finanse

Annual	2023
Przychody:	HKD104.59M
Zysk brutto:	HKD14.69M (14.05 %)
EPS:	HKD-1.060

FY	2023
Przychody:	HKD104.59M
Zysk brutto:	HKD14.69M (14.05 %)
EPS:	HKD-1.060

FY	2022
Przychody:	HKD21.60M
Zysk brutto:	HKD6.56M (30.38 %)
EPS:	HKD-1.220

FY	2021
Przychody:	HKD2.15M
Zysk brutto:	HKD919 000 (42.74 %)
EPS:	HKD-0.612

Financial Reports:

No articles found.

Shanghai MicroPort MedBot

Shanghai Microport Medbot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China and Europe. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; Honghu, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. The company also provides spine surgical robots; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery; and automated needle targeting robotics systems for percutaneous lung biopsy and percutaneous nephrolithotomy. Shanghai Microport Medbot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. Shanghai Microport Medbot (Group) Co., Ltd. operates as a subsidiary of MicroPort Scientific Corporation.